Serostim recombinant human growth hormone: Began a Phase II dose-ranging study to evaluate safety and efficacy, and to find the optimal dose regimen, as well as

Serono Laboratories Inc., Norwell, Mass. Product: Serostim recombinant human growth hormone Indication: Failure to thrive in children with HIV infection Status: Began a Phase II dose-ranging study to...